Archive for the ‘Main’ Category

Hemoptysis in the Outpatient Setting Most (72 percent) respondents held chronic bron­chitis to be the major cause of mild hemoptysis; other selections included lung cancer (11 percent), idio­pathic causes (“essential” or “cryptogenic”) (7 per­cent), tuberculosis (5 percent), and bronchiectasis (5 percent). Most (91 percent) advocated fiberoptic bron­choscopy of a 55-year-old, 80 pack-year cigarette smoker with [...]

The demographic characteristics of participants and their responses to questions about mild hemoptysis in ambulatory outpatients and life-threatening hemop­tysis in critically ill individuals were recorded. Re­sponses were entered on as many as 118 keypads, with a mean±SD of 104 ±9.1 responses per question. Seventy-nine individuals responded to over 80 percent of questions. Data from all [...]

Physicians attending an interactive session at the 1988 Annual Scientific Assembly of the ACCP answered a series of questions about the diagnosis and management of patients with hemoptysis. Responses were recorded by computer, and the proportions of answers to multiple-choice questions were tabulated for immediate feedback to the audience. Participants selected a single best answer [...]

Temoptvsis is a symptom and sign commonly evaluated by chest clinicians. Despite consider­able emphasis upon the approaches to this problem and its diverse presentations, several questions re­main: the selection of ambulatory patients for bron­choscopy and other diagnostic studies, the optimum approaches to the emergency support of individuals with life-threatening bleeding, and the best applica­tions of [...]

We treated all CMV seronegative recipients irre­spective of donor serology with anti-CMV immuno­globulins from the day of transplantation. Arguments for this strategy were that the CMV serology of the donor is not always available at the time of transplan­tation and that CMV unscreened (although bufly coat poor) blood is used during open heart surgery. More­over, [...]

In Table 1, the characteristics of the 77 heart transplant recipients are shown. A total of 41 of 77 (53 percent) patients were CMV seropositive at the time of transplantation. Twenty of the 36 CMV seronegative patients received an allograft from a seropositive donor. One CMV seronegative patient received two allografts, the first from a [...]

During a period of four years, heart transplantations were performed in 77 patients. The immunosuppressive regimen con­sisted of cyclosporin A (CsA) and prednisone. The dose of CsA was adjusted according to plasma trough levels. Endomyocardial biop­sies were performed at regular intervals. In case of a biopsy-proven rejection three times, 1 g of methylprednisolone was administered [...]

Pages: Prev 1 2 3 4 5 6 7 8 9 10 ...21 22 23 Next

top